Skip to main content

Compare Stocks

Date Range: 

 HTG Molecular DiagnosticsAstrotechScientific IndustriesPrecipioBioForce Nanosciences
SymbolNASDAQ:HTGMNASDAQ:ASTCOTCMKTS:SCNDNASDAQ:PRPOOTCMKTS:BFNH
Price Information
Current Price$3.59$1.12$10.75$4.01$1.70
52 Week RangeBuyN/AHoldBuyN/A
MarketRank™
Overall Score1.50.50.81.30.2
Analysis Score3.50.01.03.50.0
Community Score2.72.62.62.90.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.8
Earnings & Valuation Score1.30.00.60.00.0
Analyst Ratings
Consensus RecommendationBuyN/AHoldBuyN/A
Consensus Price Target$9.50N/A$8.00$7.00N/A
% Upside from Price Target164.62% upsideN/A-25.58% downside74.56% upsideN/A
Trade Information
Market Cap$22.31 million$27.57 million$28.62 million$72.71 million$25.20 million
Beta1.63-0.78-0.012.9-1.56
Average Volume140,9123,653,9012,1568,916,2304,584
Sales & Book Value
Annual Revenue$19.20 million$490,000.00$8.57 million$3.13 million$20,000.00
Price / Sales1.1656.263.5923.231,298.12
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$6.19 per share$0.08 per share$7.80 per share$1.65 per shareN/A
Price / Book0.5814.001.382.43
Profitability
Net Income$-19,300,000.00$-8,310,000.00$-700,000.00$-13,240,000.00$-50,000.00
EPS($7.65)N/A($0.46)N/AN/A
Trailing P/E RatioN/AN/AN/A0.000.00
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-194.78%-1,332.38%-10.43%-258.88%N/A
Return on Equity (ROE)-101.81%-1,607.31%-10.22%-98.29%N/A
Return on Assets (ROA)-50.43%-164.60%-7.72%-64.03%-328,192.44%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.58%0.53%N/A0.04%N/A
Current Ratio5.74%0.66%5.73%0.89%0.14%
Quick Ratio5.48%0.51%4.32%0.83%0.14%
Ownership Information
Institutional Ownership PercentageN/A2.95%N/A3.22%N/A
Insider Ownership Percentage4.60%30.00%31.90%9.70%39.54%
Miscellaneous
Employees832739542
Shares Outstanding6.21 million24.61 million2.86 million18.13 million15.27 million
Next Earnings Date8/10/2021 (Estimated)9/14/2021 (Estimated)5/21/2021 (Estimated)5/20/2021 (Estimated)5/24/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
BioForce Nanosciences (OTCMKTS:BFNH) Stock Price Down 0.6%BioForce Nanosciences (OTCMKTS:BFNH) Stock Price Down 0.6%
americanbankingnews.com - May 4 at 12:34 AM
DateCompanyBrokerageAction
5/14/2021HTG Molecular DiagnosticsSVB LeerinkLower Price Target
5/14/2021HTG Molecular DiagnosticsHC WainwrightLower Price Target
5/11/2020HTG Molecular DiagnosticsCantor FitzgeraldReiterated Rating
3/26/2020HTG Molecular DiagnosticsCraig HallumDowngrade
9/26/2019HTG Molecular DiagnosticsCanaccord GenuitySet Price Target
8/29/2018AstrotechChardan CapitalReiterated Rating
11/9/2020Scientific IndustriesKeyCorpInitiated Coverage
4/1/2021PrecipioMaxim GroupBoost Price Target
(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.